Skip to main navigation Skip to search Skip to main content

Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer

  • William D. Figg*
  • , Oliver Sartor
  • , Michael R. Cooper
  • , Alain Thibault
  • , Raymond C. Bergan
  • , Nancy Dawson
  • , Eddie Reed
  • , Charles E. Myers
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

79 Scopus citations
Original languageEnglish
Pages (from-to)412-414
Number of pages3
JournalThe American Journal of Medicine
Volume98
Issue number4
DOIs
StatePublished - Apr 1995
Externally publishedYes

Fingerprint

Dive into the research topics of 'Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer'. Together they form a unique fingerprint.

Cite this